| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Research Support, Non-U.S. Gov't
- Language: English
- [JPEN J Parenter Enteral Nutr] 2022 Mar; Vol. 46 (3), pp. 709-720. <i>Date of Electronic Publication: </i>2021 Sep 06.
- MeSH Terms: Intestinal Diseases* / therapy ; Liver Diseases* / etiology ; Liver Diseases* / metabolism ; Liver Diseases* / therapy ; Animals ; Emulsions ; Fat Emulsions, Intravenous / chemistry ; Fish Oils / chemistry ; Fish Oils / pharmacology ; Liver / metabolism ; Parenteral Nutrition ; Swine
- References: Wretlind A. Development of fat emulsions. 1981. Nutrition. 1999;15(7-8):642. ; Le HD, Fallon EM, de Meijer VE, et al. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg. 2010;19(1):27-34. ; Tillman EM. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract. 2013;28(1):30-39. ; Khalaf RT, Sokol RJ. New insights into intestinal failure-associated liver disease in children. Hepatology (Baltimore, Md). 2020;71(4):1486-1498. ; Orso G, Mandato C, Veropalumbo C, et al. Pediatric parenteral nutrition-associated liver disease and cholestasis: novel advances in pathomechanisms-based prevention and treatment. Dig Liver Dis. 2016;48(3):215-222. ; Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016;103(2):629s-34s. ; Jackson RL, White PZ, Zalla J. SMOFlipid vs intralipid 20%: effect of mixed-oil vs soybean-oil emulsion on parenteral nutrition-associated cholestasis in the neonatal population. JPEN J Parenter Enteral Nutr. 2021;45(2):339-346. ; Park HW, Lee NM, Kim JH, Kim KS, Kim S-N. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr. 2015;145(2):277-283. ; Nandivada P, Carlson SJ, Chang MI, et al. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. Adv Nutr. 2013;4(6):711-717. ; Vlaardingerbroek H, Ng K, Stoll B, et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. J Lipid Res. 2014;55(3):466-477. ; Cai W. CSPEN guidelines for nutrition support in neonates. Asia Pac J Clin Nutr. 2013;22(4):655-663. ; Lapillonne A, Fidler Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr (Edinburgh, Scotland). 2018;37(6 Pt B):2324-2336. ; Alwayn IPJ, Gura K, Nosé V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005;57(3):445-452. ; de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009;33(5):541-547. ; Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48(2):209-215. ; Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121(3):e678-86. ; Wei Y, Wang D, Topczewski F, Pagliassotti MJ. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab. 2006;291(2):E275-81. ; Hodin CM, Visschers RGJ, Rensen SS, et al. Total parenteral nutrition induces a shift in the firmicutes to bacteroidetes ratio in association with paneth cell activation in rats. J Nutr. 2012;142(12):2141-2147. ; Cahova M, Bratova M, Wohl P. Parenteral nutrition-associated liver disease: the role of the gut microbiota. Nutrients. 2017;9(9):987. ; Lavallee CM, MacPherson JAR, Zhou M, et al. Lipid emulsion formulation of parenteral nutrition affects intestinal microbiota and host responses in neonatal piglets. JPEN J Parenter Enteral Nutr. 2017;41(8):1301-1309. ; Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 fatty acids on the gut microbiota. Int J Mol Sci. 2017;18(12):2645. ; Wawrzyniak P, Noureddine N, Wawrzyniak M, et al. Nutritional Lipids and Mucosal Inflammation. Molecular Nutrition & Food Research. 2021;65(5):e1901269. ; Stoll B, Horst DA, Cui L, et al. Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs. J Nutr. 2010;140(12):2193-2200. ; Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr. 2013;162(4):793-798.e1. ; Zhang T, Wang N, Yan W, et al. Effect of a fish oil-based lipid emulsion on intestinal failure-associated liver disease in children. Euro J Clin Nutri. 2018;72(10):1364-1372. ; Jain AK, Sharma A, Arora S, et al. Preserved Gut microbial diversity accompanies upregulation of TGR5 and hepatobiliary transporters in bile acid-treated animals receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2017;41(2):198-207. ; Brunton JA, Baldwin MP, Hanna RA, Bertolo RF. Proline supplementation to parenteral nutrition results in greater rates of protein synthesis in the muscle, skin, and small intestine in neonatal Yucatan miniature piglets. J Nutr. 2012;142(6):1004-1008. ; Burrin D, Sangild PT, Stoll B, et al. Translational advances in pediatric nutrition and gastroenterology: new insights from pig models. Ann Rev Animal Biosci. 2020;8:321-354. ; Puiman P, Stoll B. Animal models to study neonatal nutrition in humans. Curr Opin Clin Nutr Metab Care. 2008;11(5):601-606. ; Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA. 2003;100(4):1751-1756. ; Miloudi K, Comte B, Rouleau T, et al. The mode of administration of total parenteral nutrition and nature of lipid content influence the generation of peroxides and aldehydes. Clin Nutri (Edinburgh, Scotland). 2012;31(4):526-534. ; Yan Y, Jiang W, Spinetti T, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38(6):1154-1163. ; Tian F, Wang J, Sun H, et al. N-3 polyunsaturated fatty acids ameliorate hepatic steatosis via the PPAR-α/CPT-1α pathway in a mouse model of parenteral nutrition. Biochem Biophys Res Commun. 2018;501(4):974-981. ; Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000;24(6):345-350. ; Wei MY, Jacobson TA. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep. 2011;13(6):474-483. ; Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Euro J Clinl Nutri. 2010;64(9):940-947. ; Lee SI, Kang KS. Omega-3 fatty acids modulate cyclophosphamide induced markers of immunosuppression and oxidative stress in pigs. Scientific Rep. 2019;9(1):2684. ; Muto M, Lim D, Soukvilay A, et al. Supplemental parenteral vitamin E into conventional soybean lipid emulsion does not prevent parenteral nutrition-associated liver disease in full-term neonatal piglets. JPEN J Parenter Enteral Nutr. 2017;41(4):575-582. ; Deplancke B, Vidal O, Ganessunker D, et al. Selective growth of mucolytic bacteria including Clostridium perfringens in a neonatal piglet model of total parenteral nutrition. Am J Clin Nutri. 2002;76(5):1117-1125. ; Liu Y, Zheng Z, Yu L, et al. Examination of the temporal and spatial dynamics of the gut microbiome in newborn piglets reveals distinct microbial communities in six intestinal segments. Scientific Rep. 2019;9(1):3453. ; Vanni E, Bugianesi E. The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance?. Hepatology (Baltimore, Md). 2009;49(6):1790-1792. ; Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009;50(1):90-97. ; Laugerette F, Vors C, Géloën A, et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutri Biochem. 2011;22(1):53-59. ; Kaliannan K, Wang B, Li X-Y, Kim K-J, Kang JX. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Scientific Rep. 2015;5:11276. ; Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe. 2007;2(6):371-382. ; Koppelmann T, Pollak Y, Mogilner J, et al. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids. Br J Nutr. 2013;109(1):89-98. ; Liu Y-J, Tang B, Wang F-C, et al. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. Theranostics. 2020;10(12):5225-5241. ; He B, Liu Y, Hoang TK, et al. Antibiotic-modulated microbiome suppresses lethal inflammation and prolongs lifespan in Treg-deficient mice. Microbiome. 2019;7(1):145. ; Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12(4):851-861. ; Thounaojam MC, Jadeja RN, Rajpurohit S, et al. Ursodeoxycholic acid halts pathological neovascularization in a mouse model of oxygen-induced retinopathy. J Clin Med. 2020;9(6):1921.
- Contributed Indexing: Keywords: bile acid metabolism; fish oil-based lipid emulsion; gut microbiome; intestinal injury; parenteral nutrition-associated liver disease
- Substance Nomenclature: 0 (Emulsions) ; 0 (Fat Emulsions, Intravenous) ; 0 (Fish Oils)
- Entry Date(s): Date Created: 20210722 Date Completed: 20220331 Latest Revision: 20220401
- Update Code: 20240513
|
